0
Cagrilintide 5mg*10vials Per Kit
Quantity
ADD TO CART
Important Notices:
· This product is sold for scientific research purposes only.
· Product is provided as a lyophilized (freeze-dried) powder in a sealed, sterile vial.
· The quantity on the label refers to the total amount of product inside each vial.
· Additional lab supplies are required for conducting research such as bacteriostatic water for reconstitution, syringes & needles to draw from the vials, and alcohol prep pads for sanitizing vial stoppers prior to needle insertion.
· Vial appearance, label, seal and cap colors may vary from product photos.
· This product is sold for scientific research purposes only.
· Product is provided as a lyophilized (freeze-dried) powder in a sealed, sterile vial.
· The quantity on the label refers to the total amount of product inside each vial.
· Additional lab supplies are required for conducting research such as bacteriostatic water for reconstitution, syringes & needles to draw from the vials, and alcohol prep pads for sanitizing vial stoppers prior to needle insertion.
· Vial appearance, label, seal and cap colors may vary from product photos.
Detail
Research-Grade Amylin Analog for Glucose Regulation Studies
Overview: Cagrilintide, an advanced synthetic analog of amylin, is engineered for research professionals focusing on metabolic disorders and glucose homeostasis. This peptide is pivotal for studying the intricate balance of blood glucose levels and the physiological mechanisms of satiety, offering promising insights into diabetes and obesity management through amylin's complementary action to insulin.
Product Specifications:
- Purity: >99% (HPLC verified)
- Formulation: Freeze-dried powder suitable for reconstitution
- Molecular Formula: C194H312N54O59S2
- Molecular Weight: Approximately 4500 g/mol
- CAS Number: 1415456-99-3
- PubChem CID: 167312356
Research Applications:
Utilized in diverse preclinical settings, Cagrilintide aids in:
- Elucidating amylin's role in blood glucose stabilization postprandially
- Investigating the complex interplay between amylin and insulin in glucose regulation
- Exploring therapeutic potentials in synergistic treatments for enhanced metabolic control
- Assessing the impact of amylin analogs on obesity and diabetes phenotypes in experimental models
Customer Reviews